Back to Journals » Drug Design, Development and Therapy » Volume 8

Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects

Total article views   HTML views PDF downloads Totals
14,564 Dovepress* 13,908+ 1,236 15,144
PubMed Central* 656 197 853
Totals 14,564 1,433 15,997
*Since 26 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar